Home World Roche says divarasib cut risk of death 44% in lung cancer trial

Roche says divarasib cut risk of death 44% in lung cancer trial

Roche says divarasib cut risk of death 44% in lung cancer trial

Written By:
Published: October 26, 2026 00:00:22 IST

Add NewsX As A Trusted Source

ZURICH, Oct 25 (Reuters) – Swiss drugmaker Roche said on Sunday its experimental lung cancer drug divarasib reduced the risk of death by 44% compared with existing treatments in a phase III study. •

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

UPDATE 5-Saudis say Riyadh airport partly reopens despite renewed Houthi threats

UPDATE 2-Ligue 1 Standings

UPDATE 2-Ligue 1 Results

UPDATE 3-Eredivisie Top Scorers

UPDATE 7-Eredivisie Summaries

LATEST NEWS

Musetti ends title drought with win in Lyon

Musetti ends title drought with win in Lyon

Roche says divarasib cut risk of death 44% in lung cancer trial

Musetti ends title drought with win in Lyon

Man United slump to another defeat as pressure mounts on Carrick

Musetti ends title drought with win in Lyon

Man United slump to another defeat as pressure mounts on Carrick

UPDATE 7-Eredivisie Summaries

Primeira Liga Top Scorers

Primeira Liga Standings

Follow Us

NewsX is India’s fastest growing English News Channel and enjoys highest viewership and highest time spent amongst educated urban Indians.

TOP CATEGORIES

QUICK LINKS

Follow Us

NewsX is India’s fastest growing English News Channel and enjoys highest viewership and highest time spent amongst educated urban Indians.

TOP CATEGORIES

Group Websites

QUICK LINKS